EAGLE ASSET MANAGEMENT INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$2,156,000
-90.5%
32,426
-92.7%
0.01%
-91.5%
Q1 2020$22,813,000
-35.3%
446,528
+0.6%
0.14%
-16.0%
Q4 2019$35,271,000
+63.0%
443,725
-0.5%
0.17%
+50.9%
Q3 2019$21,640,000
-5.8%
446,011
+2.1%
0.11%
-5.1%
Q2 2019$22,984,000436,9610.12%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders